Life Sciences Greenhouse of Central Pennsylvania

A Venture Capital Investment Company for Life Sciences Enterprises in Central Pennsylvania

  • About Us
    • About LSGPA
    • Our Team
    • Board of Directors
  • The Funding Process
  • Resources
    • The Ecosystem
    • Applicant Support
    • Why Central PA?
  • Portfolio Companies
    • Portfolio Overview
    • Devices and Diagnostics
    • Drug Discovery
    • Other
  • News and Events
    • Press Releasees
    • Video Gallery
  • Apply Now
  • Contact Us

INDIGO Biosciences Welcomes New Member to Board of Directors

August 28, 2019 By Admin

Mark McLoughlin Brings Four Decades of Healthcare Industry Experience to the Company’s Board

State College, PA (13 August 2019) – INDIGO Biosciences, Inc. (INDIGO), the recognized industry leader in nuclear receptor and in vitro toxicology testing solutions, announced the appointment of Mark McLoughlin to the Company’s Board of Directors. Mark brings four decades of healthcare industry experience to the Board.

Mark McLoughlin will lend his healthcare expertise and extensive background in laboratory and scientific products manufacturing, distribution, and tactical marketing to the INDIGO Biosciences Board of Directors, which has helped lead the company to great success throughout the years. “It is a very exciting time to join the INDIGO Board of Directors,” said Mr. McLouglin. “INDIGO has a terrific team and portfolio of innovative solutions focused on helping customers with their critical scientific decision-making process, and I’m looking forward to assisting the team s they work to bring these assets to an even wider audience.”

Most recently, Mr. McLoughlin served as Executive Vice President for Avantor (formerly VWR International) and Senior Vice President and President of the company’s Americas laboratory and distribution services from 2012 to 2018. During his tenure as President for VWR, Mr. McLoughlin was responsible for the profit and loss management of the Americas $3 billion manufacturing, distribution, and services business. He remained directly involved in multiple strategic acquisitions and led the integration of these businesses into the Americas portfolio. Prior to his role as President, Mr. McLoughlin led the category management function for VWR while also leading additional strategic and tactical marketing functions.

Mr. McLoughlin held several senior-level positions for five years at Cardinal Health before his work at VWR, filling the role of Senior Vice President of the scientific products distribution business unit in the acute care laboratory market. He completed his tenure at Cardinal Health based in Rolle, Switzerland, as Senior Vice President and Chief Marketing Officer for the manufacturing business, during which time he was responsible for all geographies outside the United States.

Earlier in his career, Mr. McLoughlin led the global critical care manufacturing business unit for Mallinckrodt prior to its acquisition by Tyco. In his five years at Mallinckrodt, he also led commercial and marketing functions, including the establishment of the company’s corporate accounts function. From 1978 to 1996, Mr. McLoughlin held various commercial and leadership roles at American Hospital Supply Corporation and Baxter Healthcare.

“Mr. McLoughlin brings a unique perspective to INDIGO’s Board of Directors,” said Fred Marroni, CEO of INDIGO Biosciences. “His passion for INDIGO’s mission is clear, and we’re excited to have his talents and leadership in manufacturing and marketing supplement the extensive experience of our Board.”

About INDIGO Biosciences, Inc.

INDIGO Biosciences, Inc. is a leading provider of nuclear receptor and in vitro toxicology solutions that accelerate scientific decision-making. INDIGO supplements the world’s largest portfolio of nuclear receptor kits and services and in vitro toxicology solutions with greater results readability, reproducibility, and faster turnaround times. Our solutions, plus supportive team and reliable science and platforms aim to reduce the time, cost, and risk associated with the discovery process. Learn more at www.indigobiosciences.com.

Filed Under: News and Events

Latest News

Saladax Biomedical Expanding Access to Antipsychotic Drug Testing With Beckman Coulter Partnership

Apr 11, 2022 | Kelsy Ketchum NEW YORK – Measuring the presence of antipsychotic drugs in a patient's system is currently a time-consuming and … Read More...

THE LIFE SCIENCES GREENHOUSE OF CENTRAL PA ANNOUNCES CHANGE IN LEADERSHIP

President and CEO Mel Billingsley, PhD, Retiring after 20 Years at Helm Harrisburg, PA  ̶  March 24, 2022.  The Life Sciences … Read More...

Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc (Saladax) is pleased to announce an exclusive distribution agreement with HLS Therapeutics … Read More...

Immunomic Therapeutics Announces Collaboration With iOncologi

ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”) a privately held clinical-stage biotechnology company focused on advancing its … Read More...

Immunomic Therapeutics Expands Board of Directors with Appointments of Two New Members

ROCKVILLE, Md.--(BUSINESS WIRE)-- Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical stage biotechnology company pioneering the study of … Read More...

Archives

  • April 2022
  • December 2021
  • August 2021
  • July 2021
  • April 2021
  • March 2021
  • January 2021
  • November 2020
  • July 2020
  • April 2020
  • January 2020
  • September 2019
  • August 2019
  • May 2019
  • March 2019
  • February 2019
  • January 2019
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • July 2017
  • June 2017
  • March 2017
  • January 2017
  • October 2016
  • September 2016
  • August 2016
  • June 2016
  • May 2016
  • January 2016

LSGPA
Life Sciences Greenhouse of Central Pennsylvania
225 Market Street
Suite 500
Harrisburg, PA  17101
1-717-635-2100

Strawberries
LSGPA Copyright © 2018

Copyright © 2022 · WordPress · Log in